Novo Nordisk: Überzeugendes Votum - Kaufsignal voraus

10:08 EDT 21 Jun 2017 | FinanzNachrichten

Der positive Newsflow reißt in diesem Jahr bei Novo Nordisk nicht ab: Ein Ausschuss der amerikanischen Zulassungsbehörde FDA hat eine Empfehlung für das Diabetes-Mittel Victoza als Therapeutikum ge...

Original Article: Novo Nordisk: Überzeugendes Votum - Kaufsignal voraus


More From BioPortfolio on "Novo Nordisk: Überzeugendes Votum - Kaufsignal voraus"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...